June 10, 2026 · Form 4 insider transaction
Sullivan Christopher Ryan sold 138 shares of Avalo Therapeutics, Inc. at $13.10 per share, a transaction worth $1.8K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Includes 588 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan as a part of this reporting transaction.